29th Mar 2005 16:16
AstraZeneca PLC29 March 2005 Dealing by Directors Companies Act 1985 Sections 324/329 We hereby inform you that on 24 March 2005 the following Director of AstraZenecaPLC was granted an option under the AstraZeneca Share Option Plan. The optionis exercisable over the Company's American Depositary Shares (ADS). One ADSequals one Ordinary Share. Name of Number of ADSs Exercise price Period when Total number of Director over which option per share exercisable ADSs under is granted option D R Brennan 110,987 US$40.35 24.3.08-23.3.15 440,643 The option will become exercisable on 24 March 2008 subject to certainperformance conditions. The conditions, which will not be subject to anyretesting, are that the earnings per share of the Company must increase by theincrease in the UK Retail Prices Index plus 5% per annum on average over threeyears, and that no significant unforeseen event has taken place which, in thereasonable opinion of the Remuneration Committee, has resulted in majorreputational damage to AstraZeneca, and the circumstances of which areexceptional enough to justify the option not vesting and becoming exercisable.Failure to satisfy either or both of these conditions will result in the lapseof the option in its entirety. G H R MuskerCompany Secretary29 March 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca